\nThe purposes of the National Cancer Patient Experience Survey, 2015 (NCPES/CPES) were:
\n
to secure continuous improvement by building on the results of the 2014 survey and to enable local providers to assess their performance improvement with other providers;
\n
to enable commissioners to assess local improvements in cancer patient experience via locally agreed Commissioning for Quality and Innovation (CQUIN) schemes;
\n
to provide NHS England with an up to date overview of cancer patient experience across England;
\n
to provide NHS Improving Quality with data on each participating trust and the areas on which quality improvement needs to be focussed; and
\n
to enable patients to make informed choices about where to go for cancer treatment via publishing the provider level analysis on publicly available websites.
\nThe 2015 data are based on the experience of an initial sample of 116,991 cancer patients, reduced to 108,272 through checking and deceased status measures, and in total 71,186 responded, either by post or online, phone or through the Quality Health translation service. The response rate was 65.7% overall, in line with the levels attained in previous years.\n \n \nThis study, SN 8164, is subject to restrictive Special Licence Access conditions, because it contains detailed data on the treatment and experiences of cancer patients. A less detailed version of the data, held under SN 8163, is available under standard End User Licence access conditions; it contains no geographic information, and less detailed demographic information. Users are advised to check SN 8163 first to see whether it is sufficient for their research requirements before considering making a Special Licence Access application for this study. \n
\n2010-2014 data unavailable: \nThe 2010-2014 NCPES End User Licence data were temporarily withdrawn at the depositor's request in October 2015; only the 2015 survey (SN 8163) is currently available. In addition, there is no Special Licence version of the 2010-2014 data; 2015 is the first year in the series for which both versions are held.\n
\n\n\n Main Topics: The data cover different stages of the patients' 'cancer journey', from diagnosis to outpatient treatment:
initial GP visits before diagnosis (how many appointments, time period)
diagnostic tests (understanding of these)
how...","sameAs":"http://doi.org/10.5255/UKDA-SN-8164-1","keywords":["CANCER","PATIENTS","MEDICAL CARE","DOCTOR-PATIENT RELATIONSHIP","HEALTH CONSULTATIONS","MEDICAL DIAGNOSIS","CLINICAL TESTS AND MEASUREMENTS","MEDICAL EXAMINATIONS","RADIOTHERAPY","CHEMOTHERAPY","NURSING CARE","HEALTH ADVICE","HOSPITAL OUTPATIENT SERVICES","AGE","ETHNIC GROUPS","GENERAL PRACTITIONERS","DRUG SIDE-EFFECTS","MEDICAL SPECIALISTS","INFORMATION SOURCES","SOCIAL SUPPORT","SURGERY","HOSPITAL ADMISSIONS","HOSPITAL SERVICES","HOME VISITS","PAIN CONTROL","GENDER","DEBILITATIVE ILLNESS","SEXUALITY","SATISFACTION WITH SERVICES","RIGHT TO PRIVACY","NURSES","PARTICIPATION","2015","England"],"variableMeasured":"Individuals, National","measurementTechnique":"Telephone interview, Postal survey, web-based survey","identifier":"10.5255/UKDA-SN-8164-1","creator":[{"@type":"Person","name":"NHS England"},{"@type":"Person","name":"Quality Health"}],"temporalCoverage":"2015-10-01/2016-03-01","spatialCoverage":"England","datePublished":"2017-04-04","dateModified":"2023-04-20"}